News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
875,676 Results
Type
Article (88326)
Company Profile (812)
Press Release (786511)
Multimedia
Podcasts (215)
Webinars (34)
Section
Business (233396)
Career Advice (4153)
Deals (39907)
Drug Delivery (161)
Drug Development (91525)
Employer Resources (206)
FDA (18470)
Job Trends (17451)
News (398267)
Policy (40004)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3033)
Academic (2)
Accelerated approval (45)
Adcomms (37)
Allergies (172)
Alliances (56985)
ALS (205)
Alzheimer's disease (1879)
Antibody-drug conjugate (ADC) (409)
Approvals (18695)
Artificial intelligence (730)
Autoimmune disease (244)
Automation (52)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (217)
Biotechnology (486)
Bladder cancer (185)
Brain cancer (72)
Breast cancer (725)
Cancer (5605)
Cardiovascular disease (494)
Career advice (3582)
Career pathing (45)
CAR-T (324)
CDC (71)
Celiac Disease (2)
Cell therapy (905)
Cervical cancer (42)
Clinical research (77762)
Collaboration (2058)
Company closure (6)
Compensation (1290)
Complete response letters (91)
COVID-19 (3011)
CRISPR (110)
C-suite (1034)
Cystic fibrosis (157)
Data (7126)
Decentralized trials (3)
Denatured (80)
Depression (174)
Diabetes (590)
Diagnostics (7399)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (357)
Drug pricing (234)
Drug shortages (37)
Duchenne muscular dystrophy (286)
Earnings (101195)
Editorial (70)
Employer branding (25)
Employer resources (174)
Events (136345)
Executive appointments (1103)
FDA (21993)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1719)
Gene editing (238)
Generative AI (77)
Gene therapy (752)
GLP-1 (1197)
Government (5500)
Grass and pollen (8)
Guidances (399)
Healthcare (20999)
HIV (80)
Huntington's disease (57)
IgA nephropathy (93)
Immunology and inflammation (320)
Immuno-oncology (91)
Indications (155)
Infectious disease (3354)
Inflammatory bowel disease (222)
Inflation Reduction Act (17)
Influenza (137)
Intellectual property (279)
Interviews (817)
IPO (17973)
IRA (61)
Job creations (5204)
Job search strategy (2869)
JPM (73)
Kidney cancer (20)
Labor market (104)
Layoffs (666)
Leadership (45)
Legal (10169)
Liver cancer (104)
Longevity (30)
Lung cancer (750)
Lymphoma (414)
Machine learning (55)
Management (66)
Manufacturing (997)
MASH (192)
Medical device (15134)
Medtech (15216)
Mergers & acquisitions (23095)
Metabolic disorders (1579)
mRNA (212)
Multiple sclerosis (181)
NASH (24)
Neurodegenerative disease (431)
Neuropsychiatric disorders (114)
Neuroscience (3390)
Neurotech (2)
NextGen: Class of 2026 (7712)
Non-profit (5130)
Now hiring (74)
Obesity (771)
Opinion (354)
Ovarian cancer (184)
Pain (244)
Pancreatic cancer (265)
Parkinson's disease (363)
Partnered (39)
Patents (575)
Patient recruitment (603)
Peanut (65)
People (67346)
Pharmaceutical (139)
Pharmacy benefit managers (35)
Phase 1 (24030)
Phase 2 (33753)
Phase 3 (25410)
Pipeline (7020)
Policy (369)
Postmarket research (3554)
Preclinical (10783)
Press Release (72)
Prostate cancer (289)
Psychedelics (61)
Radiopharmaceuticals (328)
Rare diseases (1096)
Real estate (7445)
Recruiting (81)
Regulatory (29580)
Reports (72)
Research institute (2754)
Resumes & cover letters (653)
Rett syndrome (33)
RNA editing (22)
RSV (95)
Schizophrenia (172)
Series A (291)
Series B (211)
Service/supplier (30)
Sickle cell disease (113)
Special edition (29)
Spinal muscular atrophy (182)
Sponsored (51)
Startups (4347)
State (2)
Stomach cancer (21)
Supply chain (127)
Tariffs (101)
The Weekly (132)
Vaccines (1218)
Venture capital (111)
Weight loss (522)
Women's health (115)
Worklife (23)
Date
Last 7 days (646)
Last 30 days (2734)
Last 365 days (32743)
2026 (8004)
2025 (33227)
2024 (38127)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1291)
Alabama (97)
Alaska (7)
Arizona (368)
Arkansas (15)
Asia (51837)
Australia (9105)
California (12664)
Canada (3587)
China (1312)
Colorado (541)
Connecticut (552)
Delaware (381)
Europe (119333)
Florida (1884)
Georgia (412)
Hawaii (4)
Idaho (68)
Illinois (1072)
India (86)
Indiana (589)
Iowa (24)
Japan (497)
Kansas (138)
Kentucky (50)
Louisiana (41)
Maine (85)
Maryland (1568)
Massachusetts (9273)
Michigan (388)
Minnesota (718)
Mississippi (7)
Missouri (152)
Montana (37)
Nebraska (30)
Nevada (140)
New Hampshire (90)
New Jersey (3403)
New Mexico (33)
New York (3340)
North Carolina (1727)
North Dakota (10)
Northern California (6161)
Ohio (389)
Oklahoma (25)
Oregon (54)
Pennsylvania (2524)
Puerto Rico (26)
Rhode Island (53)
South America (1668)
South Carolina (75)
South Dakota (1)
Southern California (4926)
Tennessee (204)
Texas (2022)
United States (45541)
Utah (380)
Vermont (1)
Virginia (324)
Washington D.C. (88)
Washington State (1048)
West Virginia (4)
Wisconsin (143)
Wyoming (2)
There are 875,676 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance
March 27, 2026
·
5 min read
Press Releases
OS Therapies Granted Meetings with U.S. FDA, U.K. MHRA, EMA and Australian Therapeutic Goods Administration to Review Global Confirmatory Phase 3 Trial for OST-HER2 in Metastatic Osteosarcoma
• Meetings with all four regulatory agencies scheduled to occur in the second quarter of 2026, with expected Phase 3 commencement in the third quarter of 2026 initially in Australia • Commencing the Phase 3 confirmatory study is a pre-requisite to being granted a Biologics License Application (BLA) under the Accelerated Approval Program in the U.S. and Conditional Marketing Authorisations (CMAs) in the U.K. & Europe
March 27, 2026
·
5 min read
Press Releases
Neural Therapeutics Announces Amendment to SIO Agreement, Concurrent Financing Terms, Shareholder Meeting Date and RSU Grant
March 27, 2026
·
6 min read
Press Releases
New Day Diagnostics Highlights Rising Early-Onset Colorectal Cancer Rates During Colorectal Cancer Awareness Month
March 27, 2026
·
1 min read
Press Releases
Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026
March 27, 2026
·
12 min read
Press Releases
Secretome Therapeutics Announces Participation in Upcoming Investor Conferences - March 27, 2026
March 27, 2026
·
1 min read
Press Releases
Organon Debuts New Analysis of VTAMA® (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age
March 27, 2026
·
7 min read
Press Releases
Adagio Medical Reports Fourth Quarter and Full Year 2025 Results
March 27, 2026
·
9 min read
Press Releases
ORIC® Pharmaceuticals to Report Combination Dose Optimization Data From Phase 1b Trial of Rinzimetostat in Patients with mCRPC
March 27, 2026
·
1 min read
FDA
Webinar: Aligning With the FDA on a Regulatory Pathway To Avoid Decision Day Surprises
Watch this critical discussion on how regulators and biotech companies can bridge the expectation gap during the regulatory review process to ensure novel therapies reach patients in a timely manner—because patients don’t have time to wait.
March 27, 2026
·
1 min read
·
Heather McKenzie
1 of 87,568
Next
